A high incidence ofinfections in patients with systemic lupus erythematosus (SLE) has frequently been commented upon (Harvey, Shulman, Tumulty, Conley, and Schoenrich, 1954; Jessar, LamontHavers, and Ragan, 1953; Carpenter and Sturgill, 1964; Ropes, 1964 ) and a recent study has offered some further support for this contention (Staples, Gerding, Decker, and Gordon, 1970) . At least part of the explanation for the apparent increase in susceptibility to infections in SLE may be related to the frequent therapeutic use of immunosuppressive agents in these patients. In addition, renal failure, a clinical development associated with a high incidence of infections (Montgomerie, Kalmanson, and Guze, 1968) , is common in SLE. Hypocomplementaemia is a frequent finding, particularly when active renal disease is present (Schur and Sandson, 1968) and decreased antibody responses to bacterial antigens have been described (Baum and Ziff, 1969) . Granulocytopenia may occur and bone marrow granulocyte reserves have been shown to be diminished (Kimball, Wolff, Talal, Plotz, and Decker, 1973) . In some patients phagocytosis has been found to be defective (Brandt and Hedberg, 1969; Orozco, Jasin, and Ziff, 1970) . A cellular defect in chemotaxis has been described in a single patient with SLE (Mowat and Baum, 1971a) . Another study reported normal neutrophil chemotactic responses, but serum chemotactic activity was not evaluated (Zivkovic and Baum, 1972) . In vivo leukocyte migration has been reported to be diminished in patients with SLE (Gewurz, Page, Pickering, and Good, 1967) .
The current study was undertaken to examine both serum and cellular factors in neutrophil chemotaxis in a group of 23 patients with SLE. Utilizing the in vitro Boyden chamber technique, experiments were designed to evaluate the ability of the patients' serum to generate chemotactic factors and the capacity of the patients' neutrophils to migrate in response to a chemotactic stimulus. Results were correlated with various clinical parameters of disease activity.
Methods

PATIENTS
All patients studied were hospitalized at the Clinical Center of the National Institutes of Health during the period from 1970 to 1972. The criteria for diagnosis of SLE were those of the American Rheumatism Association (Cohen, Reynolds, Franklin, Kulka, Ropes, Shulman, and Wallace, 1971) . Clinical data were gathered prospectively as part of an ongoing study of patients with SLE. The data recorded were those obtained on the same day as or within 1 or 2 days at most of the date of study of chemotactic function. Patients were not studied during or for a period of 2 months following any bout of acute infection.
CHEMOTAXIS
Polymorphonuclear leucocyte (PMN) chemotaxis was studied by a previously described modification (Clark and Kimball, 1971 ) of the method of Boyden (1962) . Generation of chemotactic factors was evaluated as follows: blood from patients and control subjects was allowed to clot at room temperature for 1 hour and the serum was used immediately or stored at -70°C. for future use. Fresh or fresh-frozen serum 0 05 ml. was added to a mixture of 0 85 ml. gelatin-veronal-buffered saline (calcium 7 x 10-5 M, magnesium 5 x 10-4 M) and 0-1 ml. 0 85 per cent. NaCl containing 30 ,ug. endotoxin (E. coli 0127:B8 lipopolysaccharide B, Difco Labs, Detroit, Mich.). In some cases 10 p,g. of insoluble immune complexes (rabbit anti-human serum albumin combined with human serum albumin at equivalence) was used in place ofthe endotoxin. Chemotactic factors were generated by incubating this mixture at 37°C. for 60 min. and residual complement was then inactivated by heating at 56°C. for 30 min. After dilution in 1-0 ml. Gey's medium (Clark and Kimball, 1971 ), these samples were tested for chemotactic activity.
Blood granulocytes from patients and control subjects were harvested by a previously described method (Clark and Kimball, 1971) employing dextran sedimentation and hypotonic lysis of erythrocytes. Final cell suspensions (2-3 x 106 granulocytes/ml. Gey's medium) averaged 75-80 per cent. granulocytes in patients and controls. These cells were tested for their ability to respond to chemotactic factor generated from autologous patient serum and normal control serum.
Chemotaxis chambers consisted of an upper compartment containing the cell suspension (0-8 ml.) and separated from the lower compartment containing the chemotactic factor by a 3 p. micropore filter (Sartorius Membran-filter, Gottingen, West Germany). After a 3-hour incubation at 37°C. in S per cent. CO2 with 100 per cent. humidity, the filters were removed and stained. The number of cells having migrated through to the lower surface of the filter were counted in five to ten random fields and the chemotactic activity determined as the average number of cells/ (Steinberg, Pincus, and Talal, 1971 ) and greater than 36 per cent. binding was considered abnormal. Immunodiffusion plates were used to measure C3 (Hyland Laboratories, Los Angeles, Cal.; normal 119-175 mg. per cent., C4 (Meloy Laboratories, Springfield, Va.; normal 20-60 mg. percent., and immunoglobulins (Meloy Laboratories; normal 7-7-11-3 mg./ml. for IgG, 0-8-2-0 for IgA, and 0-9-1 7 for IgM). The presence of tubuloreticular structures was evaluated as described elsewhere (Grimley, Decker, Michelitch, and Frantz, 1973 
Results
Generation ofchemotactic activity in SLE sera The amount of PMN chemotactic factor generated by endotoxin activation of serum from 23 patients with SLE is tabulated in Table I (col. 1). Chemotactic activity in ten of these sera was significantly reduced from normal (25 to 58 per cent. of control). Three additional sera were defective to a lesser degree (71 to 81 per cent. of control), although in these instances the reduction was not significant. Ten sera were clearly normal (97 to 124 per cent. of control).
Two of the defective sera were activated with immune complexes as well as endotoxin; similar reductions in the amount of chemotactic activity generated were observed with both activating agents (Table I) . Serial samples of serum were studied in seven of the patients. In six of these no major changes were observed, but in one subject (case 5) five sera obtained over a 3-month period showed a gradual decrease from 62 to 33 per cent. of normal. The patient's clinical course during this interval remained stable.
Several clinical parameters were tabulated for the entire study group. In Table II the group of thirteen patients with depressed serum chemotactic activity are compared with the ten patients with normal activity. The three subjects with intermediate activity were considered with the abnormal group for this analysis, but no major effect on the data was observed when these three were either omitted or included with the normal activity group. As can be seen, several parameters correlated with serum chemotactic activity. The group with depressed activity was significantly younger at the time of study and were younger at the time of onset of disease. Age at onset ofrenal involvement correlated similarly. Duration of disease tended to be longer, but this was not significant. The level of serum DNA-binding activity showed a significant negative correlation with serum chemotactic activity. Both IgG and IgA levels in serum showed strong positive correlations Table II , she did not differ significantly from the group as a whole. She did, however, have sarcoidosis and poorly controlled adult onset diabetes mellitus with blood sugar levels frequently exceeding 400 mg. per cent. This patient's serum chemotactic activity was normal (97 per cent. of control). In addition, for the entire group, there was no correlation between PMN chemotactic responsiveness and serum chemotactic activity.
Discussion
The data presented demonstrate defective serum generation of PMN chemotactic factors in approximately half of a group of 23 patients with SLE. This defect seemed to occur in a sub-group of patients who were younger, had an earlier age at onset of disease, high DNA-binding, and low immunoglobulin levels. It is difficult to establish cause and effect relationships among these various correlated factors. However, the finding that the group of patients with abnormal generation of serum chemotactic factors had a significantly higher incidence of infection suggests that this defect may contribute to the increased susceptibility to infection in SLE.
Some comments regarding the immunoglobulin levels and their correlation with serum chemotactic activity are in order. Previous studies have reported elevated globulins, especially IgG, in a certain percentage of SLE patients (Cass, Mongan, Jacox, and Vaughan, 1968) . Similar elevations were found in the present group of subjects. Ofthe 23 patients, increased levels of IgG, IgA, and IgM were noted in six, eight, and seven respectively. The IgG elevations were the most striking, with levels as high as 21 8 mg./ml. Contrasting with previous reports, however, was the unexpected finding of diminished globulin levels in some patients (IgG twelve subjects; IgA five subjects; and IgM nine subjects). This was occasionally quite striking with levels for IgG as low as 1-13 mg./ml. These determinations were all performed on at least two separate occasions. In only two of the patients with low IgG levels could this be ascribed to treatment with immunosuppressive agents. As noted previously and documented in Table II , there was a significant correlation between the hypogammaglobulinaemia and decreased serum chemotactic activity. Although serum defects in chemotaxis have been reported in association with hypogammaglobulinaemia (Clark and Kimball, 1971; Steerman, Snyderman, Leiken, and Colten, 1971) , there is no evidence that low globulin levels per se could account for depressed serum chemotactic activity. The lack of correlation between serum levels of C3 and C4 and chemotactic activity is of interest in view of the fact that generation of chemotactic factors by endotoxin or immune complexes is a complement mediated process (Snyderman and Mergenhagen, 1972) . Endotoxin which was used for most of the studies utilizes the alternate pathway of complement activation which involves C3, but not C4 (Frank, May, Gaither, and Ellman, 1971) . In general the C3 and C4 levels in the patients were not so low as to be expected to limit the rate of these reactions, but even with a C3 level as low as 38 mg. per cent. in one subject, normal serum chemotactic activity was generated.
The correlations between diminished serum chemotactic activity and younger age, earlier onset of disease, and high DNA-binding are difficult to explain satisfactorily, although these parameters may simply relate to more severe disease. Corticosteroids in the doses employed had no appreciable effect on serum chemotactic activity. In animals, advanced renal failure has been shown to cause depressed serum chemotactic activity (Clark, Hamory, Ford, and Kimball, 1972) . A lack ofcorrelation between various parameters of renal function and serum chemotactic activity in the current study is most likely due to the relatively mild degree of azotaemia present (highest urea nitrogen 45 mg. per cent.) in spite of documented kidney involvement in all but two patients. In fact, it should be noted that patients with severe fulminant SLE were not heavily represented in this study.
It is interesting to speculate on a possible relationship between the in vivo serum chemotactic defect described here and the in vivo defect in leucocyte migration in SLE noted by Gewurz and others (1967) using the skin-window technique. It is tempting to ascribe both of these observations to a common serum defect, such as partial or complete absence of a necessary serum component or the presence in the serum of an inhibitory factor. However, the exact nature of the chemotactic factors involved in the skin-window response and whether serum components such as complement are involved in this system have not been firmly established. Therefore, no necessary connection between the in vitro and in vivo defects can be asserted at the present time.
In contrast to the serum chemotactic defect described, neutrophils from SLE patients exhibited normal chemotactic responses in all but one subject. As noted, this patient also had sarcoidosis and diabetes mellitus. Normal neutrophil chemotaxis has been reported in sarcoidosis (Clark and Kimball, 1971) , but a cellular defect in PMN chemotaxis has been described in diabetes mellitus (Mowat and Baum, 1971b 
